Evidence map›Paper›PMID 40259886›Full record

ArticleActa biochimica et biophysica Sinica2025

D-mannose suppresses the angiogenesis and progression of colorectal cancer.

Yu Du, Xinchao Zhang, Yixin Xu, Yuefan Zhou, Yanping Xu

Abstract read
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu DuNourse Centre for Pet Nutrition, Wuhu 241200, China.
Xinchao ZhangTongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.
Yixin XuNourse Centre for Pet Nutrition, Wuhu 241200, China.
Yuefan ZhouTongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.
Yanping XuTongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis is an important factor influencing the development of solid tumors, and vascular endothelial growth factor receptor-2 (VEGFR2) is a central regulator of angiogenesis. Antibodies and inhibitors against VEGFR2 have been widely used in various malignancies. However, the regulatory mechanism of VEGFR2 has not been fully clarified. Here, we show that D-mannose can significantly inhibit angiogenesis and tumor growth by degrading VEGFR2. Specifically, D-mannose inactivates GSK3β by promoting the phosphorylation of GSK3β at Ser9, enhances the nuclear translocation of TFE3, and promotes lysosomal biogenesis, thereby increasing the lysosome-mediated degradation of VEGFR2. Thus, D-mannose significantly inhibits the proliferation, migration, and capillary formation of human umbilical vein endothelial cells (HUVECs)

Indexed as

Colorectal NeoplasmsMannoseNeovascularization, PathologicAngiogenesisAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell Line, TumorCell MovementCell ProliferationDisease ProgressionGlycogen Synthase Kinase 3 betaHumansHuman Umbilical Vein Endothelial CellsMiceMice, Inbred BALB CMice, NudeBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGlycogen Synthase Kinase 3 betaKDR protein, humanMannoseVascular Endothelial Growth Factor Receptor-2CRCD-mannoseGSK3βlysosomeTFE3VEGFR2

Identifiers

PMID40259886
PMCPMC12368525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.